Publication | Closed Access

Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer

Off-target EffectMedicineImmunologyCrispr-edited T CellsBronchial NeoplasmGene EditingCrisprLung CancerImmune Cell TherapyOncologyCell BiologyGenome EditingCancer Research